HURA vs. ACRV
HURA (TuHURA Biosciences, Inc.) and ACRV (Acrivon Therapeutics Inc. Common Stock) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, HURA returned -75.47%/yr vs -50.62%/yr for ACRV. Their 0.09 correlation means their historical movements had little consistent relationship.
Performance
HURA vs. ACRV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HURA achieves a 186.77% return, which is significantly higher than ACRV's -37.76% return.
HURA
- 1D
- 0.00%
- 1M
- -11.07%
- 6M
- 305.53%
- YTD
- 186.77%
- 1Y
- -9.58%
- 3Y*
- -75.47%
- 5Y*
- -75.95%
- 10Y*
- -66.72%
- ALL TIME*
- -55.20%
ACRV
- 1D
- -1.32%
- 1M
- -12.79%
- 6M
- -16.20%
- YTD
- -37.76%
- 1Y
- 19.05%
- 3Y*
- -50.62%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- -44.55%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $467.58K | $869.81K | $779.27K | |
| $393.30K | $678.40K | $1.25M |
HURA vs. ACRV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
HURA TuHURA Biosciences, Inc. | 186.77% | -81.50% | -31.10% | -97.54% | 53.46% |
ACRV Acrivon Therapeutics Inc. Common Stock | -37.76% | -59.97% | 22.36% | -57.29% | -13.71% |
Correlation
The correlation between HURA and ACRV is 0.18, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.18 |
Correlation (3Y) Balances recent behavior with more history. | 0.12 |
Correlation (All Time) Calculated using the full available price history since Nov 15, 2022 | 0.09 |
Fundamentals
HURA:
$138.19M
ACRV:
$64.20M
HURA:
-$0.58
ACRV:
-$2.00
HURA:
$0.00
ACRV:
$0.00
HURA:
-$17.64K
ACRV:
$311.00K
HURA:
-$28.68M
ACRV:
-$84.65M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HURA vs. ACRV — Risk / Return Rank
HURA
ACRV
HURA vs. ACRV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for TuHURA Biosciences, Inc. (HURA) and Acrivon Therapeutics Inc. Common Stock (ACRV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HURA | ACRV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.28 | ||
| Sortino ratioReturn per unit of downside risk | -0.05 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.13 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | -0.15 | 0.30 | -0.45 |
| Martin ratioReturn relative to average drawdown | -0.29 | 0.52 | -0.81 |
Loading charts...
Drawdowns
HURA vs. ACRV - Drawdown Comparison
The maximum HURA drawdown since its inception was -100.00%, roughly equal to the maximum ACRV drawdown of -95.47%. Use the drawdown chart below to compare losses from any high point for HURA and ACRV.
Loading charts...
Drawdown Indicators
| HURA | ACRV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -95.47% | -4.53% |
Max Drawdown (1Y)Largest decline over 1 year | -86.46% | -57.14% | -29.32% |
Max Drawdown (3Y)Largest decline over 3 years | -99.74% | -91.53% | -8.21% |
Max Drawdown (5Y)Largest decline over 5 years | -99.98% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -93.53% | -6.47% |
Average DrawdownAverage peak-to-trough decline | -88.43% | -71.30% | -17.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 43.53% | 33.25% | +10.28% |
Volatility
HURA vs. ACRV - Volatility Comparison
The current volatility for TuHURA Biosciences, Inc. (HURA) is 14.10%, while Acrivon Therapeutics Inc. Common Stock (ACRV) has a volatility of 23.22%. This indicates that HURA experiences smaller price fluctuations and is considered to be less risky than ACRV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HURA | ACRV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.10% | 23.22% | -9.12% |
Volatility (6M)Calculated over the trailing 6-month period | 98.58% | 53.21% | +45.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 134.77% | 93.40% | +41.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 140.53% | 103.36% | +37.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 128.38% | 103.36% | +25.02% |
Dividends
HURA vs. ACRV - Dividend Comparison
Neither HURA nor ACRV has paid dividends to shareholders.
Financials
HURA vs. ACRV - Financials Comparison
This section allows you to compare key financial metrics between TuHURA Biosciences, Inc. and Acrivon Therapeutics Inc. Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
HURA and ACRV have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACRV has higher volatility (23.22%) compared to HURA (14.10%). In terms of maximum drawdown, HURA dropped -100.00% vs ACRV's -95.47%.
ACRV currently has the higher Sharpe Ratio (0.18 vs -0.09), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HURA and ACRV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer